These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9387308)
1. [Treatment of malignant ascites by intraperitoneal carboplatin following massive paracentesis]. Cheng H; Gao H; Chen Z Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):476-8. PubMed ID: 9387308 [No Abstract] [Full Text] [Related]
2. [A case of peritonitis carcinomatosa due to advanced gastric cancer effectively treated by intraperitoneal injection of carboplatin]. Kurosumi M; Horii Y; Aizaki M; Kishi S; Anzai T Gan To Kagaku Ryoho; 1991 Aug; 18(10):1699-701. PubMed ID: 1872626 [TBL] [Abstract][Full Text] [Related]
3. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients. Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous placement of peritoneal port-catheter in patients with malignant ascites. Ozkan O; Akinci D; Gocmen R; Cil B; Ozmen M; Akhan O Cardiovasc Intervent Radiol; 2007; 30(2):232-6. PubMed ID: 17206391 [TBL] [Abstract][Full Text] [Related]
5. Current and future options in the treatment of malignant ascites in ovarian cancer. Woopen H; Sehouli J Anticancer Res; 2009 Aug; 29(8):3353-9. PubMed ID: 19661355 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis and management of refractory malignant ascites]. Saâda E; Follana P; Peyrade F; Mari V; François E Bull Cancer; 2011 Jun; 98(6):679-87. PubMed ID: 21636346 [TBL] [Abstract][Full Text] [Related]
7. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis]. Mizuno I; Yasui T; Takeyama H; Ishikawa M; Terada J; Mohri N; Ueda T; Sumita N; Kobayashi K; Akamo Y Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769 [TBL] [Abstract][Full Text] [Related]
8. Malignant ascites: past, present, and future. Adam RA; Adam YG J Am Coll Surg; 2004 Jun; 198(6):999-1011. PubMed ID: 15194082 [No Abstract] [Full Text] [Related]
9. Clinical pathological exercise: Adenocarcinoma of the stomach with metastasis to the liver. Binder HJ Pahlavi Med J; 1976 Jul; 7(3):407-16. PubMed ID: 967515 [No Abstract] [Full Text] [Related]
10. [Effects of intraperitoneal injection of low-dose CDDP on 3 patients with ascites owing to peritonitis carcinomatosa of gastric and colorectal carcinoma]. Kitani K; Morimoto T; Shibata N; Amano K; Nakahira S; Morita S; Tanaka T; Nomura T; Okuda H Gan To Kagaku Ryoho; 2001 Oct; 28(11):1666-8. PubMed ID: 11708004 [TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis. Seike M; Maetani I; Sakai Y J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)]. Katano M Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499 [No Abstract] [Full Text] [Related]
14. Ascites in a woman with chronic mitral stenosis. Litam PP; Smaha LA Hosp Pract (Off Ed); 1991 May; 26(5A):35-6, 38. PubMed ID: 2033099 [No Abstract] [Full Text] [Related]
15. Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer. Fujiwara K Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():354-8. PubMed ID: 10895180 [No Abstract] [Full Text] [Related]
16. [Preoperative intraperitoneal versus intravenous carboplatin chemotherapy for advanced gastric cancer, pharmacokinetics and drug accumulation study]. Wang J; Chen J; Ma S Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):300-2. PubMed ID: 11038765 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108. Jordan K; Luetkens T; Gog C; Killing B; Arnold D; Hinke A; Stahl M; Freier W; Rüssel J; Atanackovic D; Hegewisch-Becker S Eur J Cancer; 2016 Aug; 63():127-34. PubMed ID: 27314448 [TBL] [Abstract][Full Text] [Related]
18. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa]. Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071 [TBL] [Abstract][Full Text] [Related]
19. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis. Jeffries MA; Stern MA; Gunaratnam NT; Fontana RJ Am J Gastroenterol; 1999 Oct; 94(10):2972-6. PubMed ID: 10520854 [TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer. Gotlieb WH; Feldman B; Feldman-Moran O; Zmira N; Kreizer D; Segal Y; Elran E; Ben-Baruch G Gynecol Oncol; 1998 Dec; 71(3):381-5. PubMed ID: 9887235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]